Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A. by Griffiths, K, Pathan, A, Minassian, A, Sander, C, Beveridge, N, Hill, A, Fletcher, H, McShane, H

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining by Smith, S, Lalor, M, Gorak-Stolinska, P, Blitz, R, Beveridge, N, Worth, A, McShane, H, Dockrell, H

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel mycobacterium tuberculosis vaccine MVA85A by Griffiths, K, Pathan, A, Minassian, A, Sander, C, Beveridge, N, Hill, A, Fletcher, H, McShane, H

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials by Pathan, A, Sander, C, Fletcher, H, Poulton, I, Alder, N, Beveridge, N, Whelan, K, Hill, A, Mcshane, H

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials. by Pathan, A, Sander, C, Fletcher, H, Poulton, I, Alder, N, Beveridge, N, Whelan, K, Hill, A, McShane, H

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials. by Beveridge, N, Fletcher, H, Hughes, J, Pathan, A, Scriba, T, Minassian, A, Sander, C, Whelan, K, Dockrell, H, Hill, A, Hanekom, W, Mcshane, H

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. by Sander, C, Pathan, A, Beveridge, N, Poulton, I, Minassian, A, Alder, N, Van Wijgerden, J, Hill, A, Gleeson, F, Davies, R, Pasvol, G, Mcshane, H

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. by Beveridge, N, Price, D, Casazza, J, Pathan, A, Sander, C, Asher, T, Ambrozak, DR, Precopio, M, Scheinberg, P, Alder, N, Roederer, M, Koup, R, Douek, D, Hill, A, Mcshane, H

Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing. by Sharpe, SA, Mcshane, H, Dennis, M, Basaraba, R, Gleeson, F, Hall, G, McIntyre, A, Gooch, K, Clark, S, Beveridge, N, Nuth, E, White, A, Marriott, A, Dowall, S, Hill, A, Williams, A, Marsh, P

CD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults by Beveridge, N, Minassian, A, Rowland, R, Poulton, I, Satti, I, Harris, S, Poyntz, H, Hamill, M, Griffiths, K, Sander, C, Ambrozak, D, Price, D, Hill, B, Casazza, J, Douek, D, Koup, R, Roederer, M, Winston, A, Ross, J, Sherrad, J, Rooney, G, Williams, N, Lawrie, A, Fletcher, H, Pathan, A

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults by Minassian, A, Rowland, R, Beveridge, N, Poulton, I, Satti, I, Harris, S, Poyntz, H, Hamill, M, Griffiths, K, Sander, C, Ambrozak, DR, Price, D, Hill, B, Casazza, J, Douek, D, Koup, R, Roederer, M, Winston, A, Ross, J, Sherrard, J, Rooney, G, Williams, N, Lawrie, A, Fletcher, H, Pathan, A, McShane, H